From Diagnosis to Treatment: Why Genetic Testing and Innovation Matter for ATTR Amyloidosis

Amyloidosis is a serious, rare disease caused by misfolded proteins that form amyloid deposits in tissues and organs. Greater awareness, early genetic testing and proactive screening can help shorten the diagnostic journey for individuals and families affected by ATTR amyloidosis.